Overview
Kana Okada practices in Chikusa, Japan. Okada is rated as an Experienced expert by MediFind in the treatment of Histiocytosis. Their top areas of expertise are Dendritic Cell Tumor, Follicular Lymphoma, Histiocytosis, and Reticulohistiocytoma.
Their clinical research consists of co-authoring 8 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Histiocytosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Dendritic Cell TumorOkada isExperienced. Learn about Dendritic Cell Tumor.
- Follicular LymphomaOkada isExperienced. Learn about Follicular Lymphoma.
- HistiocytosisOkada isExperienced. Learn about Histiocytosis.
- ReticulohistiocytomaOkada isExperienced. Learn about Reticulohistiocytoma.